Glenmark Life Sciences's quarterly market cap
increased
from Sep. 2023 (₹75,667 Mil) to Dec. 2023 (₹80,512 Mil) and
increased
from Dec. 2023 (₹80,512 Mil) to Mar. 2024 (₹94,995 Mil).
Glenmark Life Sciences's annual market cap
declined
from Mar. 2022 (₹56,240 Mil) to Mar. 2023 (₹47,982 Mil) but then
increased
from Mar. 2023 (₹47,982 Mil) to Mar. 2024 (₹94,995 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Glenmark Life Sciences's Enterprise Value for Today is ₹102,428 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Glenmark Life Sciences's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glenmark Life Sciences's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glenmark Life Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Glenmark Life Sciences's Market Cap falls into.
Glenmark Life Sciences Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Glenmark Life Sciences's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glenmark Life Sciences (BOM:543322) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Glenmark Life Sciences Market Cap Related Terms
Thank you for viewing the detailed overview of Glenmark Life Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Glenmark Life Sciences (BOM:543322) Business Description
Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543322 has been successfully added to your 